Journal article icon

Journal article

Evidence review of hydroxyurea for the prevention of sickle cell complications in low-income countries.

Abstract:

Hydroxyurea is widely used in high-income countries for the management of sickle cell disease (SCD) in children. In Kenyan clinical guidelines, hydroxyurea is only recommended for adults with SCD. Yet many deaths from SCD occur in early childhood, deaths that might be prevented by an effective, disease modifying intervention. The aim of this review was to summarise the available evidence on the efficacy, effectiveness and safety of hydroxyurea in the management of SCD in children below 5 year...

Expand abstract
Publication status:
Published

Actions


Access Document


Authors


Karumbi, J More by this author
Kitonyi, G More by this author
Thoithi, G More by this author
Expand authors...
Journal:
Archives of disease in childhood
Volume:
98
Issue:
11
Pages:
908-914
Publication date:
2013-11-05
DOI:
EISSN:
1468-2044
ISSN:
0003-9888
URN:
uuid:f1982838-b69a-4a5d-bd1a-511c0645f3ec
Source identifiers:
429529
Local pid:
pubs:429529

Terms of use


Metrics



If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP